Continued suppression of bone turnover following a single dose of zoledronic acid: Time to re-think dosing intervals in the management of bone metastases?
Christine E. Simmons
Research Funding - Novartis
Pamela Jean Goodwin
No relevant relationships to disclose
Sophie Hogeveen
No relevant relationships to disclose
Mark Clemons
No relevant relationships to disclose
Rashida Haq
No relevant relationships to disclose
Christine B. Brezden
No relevant relationships to disclose
Jalal Ebrahim
No relevant relationships to disclose
Dolly Han
No relevant relationships to disclose